VUNO Inc.

VUNO Inc. was founded by three insightful leaders in December 2014 when the global AI-based medical industry was at an embryonic stage. They aimed to realize the infinite possibilities of AI technology in the field of medicine, building upon the pioneering success of making deep learning-based services available on the market. Widely acclaimed as a true pioneer in AI-based medical devices, VUNO Inc. proudly boasts that VUNO Med- BoneAge became the first-ever AI-based medical device in Korea. More than 7 years’ field experience has enabled the developer to build up the technological competence and expertise on the entire life cycle of AI-based medical solution technology.

VUNO’s Key Milestones

2021

2020

2019

2018

2017

2015

2014

VUNO’s Key Milestones

2021

.02

History

Listed on KOSDAQ

2020

.12

History

VUNO Med-Promise-I regulatory approved by MFDS
VUNO Med-DeepBrain AD regulatory approved by MFDS (Class III)

.12

Award

VUNO designated as the 1st Innovative Medical Device Company
VUNO certified by KIPA for IP management

.09

Award

VUNO Med-DeepCARS designated as the 6th Innovative Medical Device
VUNO Med-DeepCARS Became Innovative Medical Device (MFDS)

.07

Award

VUNO Med-Fundus AI Became Korea's First-ever Innovative Medical Device (MFDS)

.06

History

Five VUNO Med solutions - CE marked

.04

Award

VUNO Med-Chest X-Ray Won at MSIT’s “Korea SW Awards”
Ranked 1st in macular degeneration & diabetic retinopathy detection challenge (IEEE’s “ISBI 2020”)

.04

History

VUNO Med-Fundus AI regulatory approved by MFDS (Class III)
VUNO Med-Lung CT AI regulatory approved by MFDS

2019

.12

Award

Top award in Intelligence Information at ICT INNOFESTA 2019 hosted by Ministry of Science & ICT
Health Minister’s Award for “Contributions in Health & Medical Technology”

.12

History

VUNO Med-Lung CT approved in Japan

.11

Award

Top 16th (top 1.1%) at Kaggle’s “RSNA ICH Challenge 2019”

.08

History

VUNO Med-Chest X-Ray regulatory approved by MFDS

.06

History

VUNO Med-DeepBrain regulatory approved by MFDS

2018

.11

Award

Top 23rd (top 1.5%) in Kaggle’s “RSNA Pneumonia Detection Challenge 2018”

.09

Award

Ranked 2nd at MICCAI’s “Retinal Fundus Glaucoma Challenge”

.08

Award

Silver award at KIPO’s “2018 ICT IP Awards”

.06

Award

Top award at KIISS’s “IntelligentProduct Awards”

.06

History

Commercialized VUNO Med-Deep ASR (medical speech dictation SW)

.05

History

VUNO Med-BoneAge regulatory approved by MFDS as a Korea’s 1st AI medical device

.04

Award

1st place in SW for diabetic retinopathy analysis at IEEE’s “ISBI 2018”

.01

Award

Won 2018 IDC DX Awards

2017

.11

History

Participated in drafting MFDS regulatory approval guidelines for medical AI devices

2015

.12

Award

Top 5th in CLS of ImageNet “ILSVRC 2015”

.06

History

Developed VUNO Net, its own proprietary machine learning engine

.05

Award

Ranked 3rd in Global Brain(VC)’s “beGlobal Startup Battle”

2014

.12

History

VUNO was founded